牛乳脂共轭亚油酸研究现状

论述CLA的天然来源及活性成分，牛乳脂CLA的来源，牛品种、季节变化、日粮中不同脂肪来源、饲喂方式、分子生物学与细胞学对牛乳脂CLA含量的影响，加工贮存条件、加工中添加物和发酵菌种对乳制品中CLA含量的影响及CLA应用现状和安全性评价等方面。     

Factors affecting conjugated linoleic acid content in milk and meat

Conjugated linoleic acid (CLA) has been recently studied mainly because of its potential in protecting against cancer, atherogenesis, and diabetes. Conjugated linoleic acid (CLA) is a collective term for a series of conjugated dienoic positional and geometrical isomers of linoleic acid, which are found in relative abundance in milk and tissue fat of ruminants compared with other foods. The cis-9, trans-11 isomer is the principle dietary form of CLA found in ruminant products and is produced by partial ruminal biohydrogenation of linoleic acid or by endogenous synthesis in the tissues themselves. The CLA content in milk and meat is affected by several factors, such as animal's breed, age, diet, and management factors related to feed supplements affecting the diet. Conjugated linoleic acid in milk or meat has been shown to be a stable compound under normal cooking and storage conditions. Total CLA content in milk or dairy products ranges from 0.34 to 1.07% of total fat. Total CLA content in raw or processed beef ranges from 0.12 to 0.68% of total fat. It is currently estimated that the average adult consumes only one third to one half of the amount of CLA that has been shown to reduce cancer in animal studies. For this reason, increasing the CLA contents of milk and meat has the potential to raise the nutritive and therapeutic values of dairy products and meat.     

A conjugated linoleic acid supplement containing trans-10, cis-12 conjugated linoleic acid reduces milk fat synthesis in lactating goats

The effect of conjugated linoleic acid (CLA) supplements containing trans-10, cis-12 for reducing milk fat synthesis has been well described in dairy cows and sheep. Studies on lactating goats, however, remain inconclusive. Therefore, the current study investigated the efficacy of a lipid-encapsulated trans-10, cis-12 CLA supplement (LE-CLA) on milk production and milk fatty acid profile in dairy goats. Thirty multiparous Alpine lactating goats in late lactation were used in a 3 × 3 Latin square design (14-d treatment periods separated by 14-d intervals). Does were fed a total mixed ration of Bermuda grass hay, dehydrated alfalfa pellets, and concentrate. Does were randomly allocated to 3 treatments: A) unsupplemented (control), B) supplemented with 30 g/d of LE-CLA (low dose; CLA-1), and C) supplemented with 60 g/d of LE-CLA (high dose; CLA-2). Milk yield, dry matter intake, and milk protein content and yield were unaffected by treatment. Compared with the control, milk fat yield was reduced 8% by the CLA-1 treatment and 21% by the CLA-2 treatment, with milk fat content reduced 5 and 18% by the CLA-1 and CLA-2 treatments, respectively. The reduction in milk fat yield was due to decreases in both de novo fatty acid synthesis and uptake of preformed fatty acids. Milk fat content of trans-10, cis-12 CLA was 0.03, 0.09, and 0.19 g/100 g of fatty acids for the control, CLA-1, and CLA-2 treatments, respectively. The transfer efficiency of trans-10, cis-12 CLA from the 2 levels of CLA supplement into milk fat was not different between treatments and averaged 1.85%. In conclusion, trans-10, cis-12 CLA reduced milk fat synthesis in lactating dairy goats in a manner similar to that observed for lactating dairy cows and dairy sheep. Dose-response comparisons, however, suggest that the degree of reduction in milk fat synthesis is less in dairy goats compared with dairy cows and dairy sheep.     

Effects of amide-protected and lipid-encapsulated conjugated linoleic acid supplements on milk fat synthesis

The trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is a potent inhibitor of milk fat synthesis; its ability to reduce milk fat output in a controlled manner as a feed supplement, has potential management applications in the dairy industry. The effectiveness of dietary supplements of trans-10, cis-12 CLA is related to the extent to which their metabolism by rumen bacteria is minimized. A number of processes have been used to manufacture "rumen-protected" feed supplements, and their efficacy can be described by the extent of protection from rumen bacteria as well as postruminal bioavailability. The objective of this study was to investigate the effects of 2 rumen-protected CLA supplements on milk fat synthesis. Using the same initial batch of CLA, supplements were manufactured by the formation of fatty acyl amide bonds or by lipid encapsulation. Three rumen fistulated Holstein cows were randomly assigned in a 3 x 3 Latin square experiment. Treatments were 1) no supplement (control), 2) amide-protected CLA supplement, and 3) lipid-encapsulated CLA supplement. Supplements were fed to provide 10 g/d of the trans-10, cis-12 CLA isomer. Over the 7-d treatment period, 21 and 22% reductions in milk fat yield were observed for the amide-protected and lipid-encapsulated supplements, respectively. Transfer of trans-10, cis-12 CLA into milk fat was also similar for the amide-protected (7.1%) and lipid-encapsulated (7.9%) supplements. Overall, the amide-protected and lipid-encapsulated CLA supplements were equally effective at reducing milk fat synthesis and had no effect on milk yield or dry matter intake.     

Increasing amounts of conjugated linoleic acid progressively reduces milk fat synthesis immediately postpartum

Mixed conjugated linoleic acid (CLA) isomers decrease milk fat synthesis during established lactation, but their ability to cause milk fat depression (MFD) immediately postpartum remains unclear. Multiparous Holstein cows (n = 19) were randomly assigned to 1 of 4 doses of rumen-protected (RP) CLA supplements (0, 200, 400, and 600 g/d); each dose provided equal amounts of fatty acids by replacing and balancing treatments with an RP supplement of palm fatty acid distallate. Doses provided a total of 468 g fatty acids/d and 0, 62, 125, or 187 g of mixed CLA isomers/d, respectively. The CLA supplement contained a variety of CLA isomers: 5.4% trans-8, cis-10; 6.3% cis-9, trans-11; 7.9% trans-10, cis-12; and 8.2% cis-11, trans-13 CLA. Each group received treatments from approximately -10 to 21 d relative to calving. To improve palatability and ensure complete consumption, doses were mixed with equal amounts of steam-flaked corn and dried molasses; one-half the supplement was fed at 0600 h, and the remaining supplement was fed at 1800 h. Milk yield and individual feed intake were recorded daily, and milk samples were obtained from each cow every 2nd day (at both milkings) starting on d 1 postpartum. There were no differences in dry matter intake (17.1 kg/d), milk yield (34.2 kg/d), protein content (3.74%), lactose content (4.61%), or yield of milk protein or lactose. The CLA supplementation decreased overall milk fat content in a dose-responsive manner (4.57, 3.97, 3.32, and 3.10, respectively), and milk fat yield displayed the same progressive decline. The dose-dependent decrease in milk fat content was evident during wk 1 and became highly significant during wk 2 and 3. The milk fat yield response pattern was similar, and by d 21, the highest RP-CLA supplement decreased milk fat content and yield by 49 and 56%, respectively. These data clearly indicate RP-CLA can markedly (40 to 50%) induce MFD immediately postpartum without negatively affecting other production parameters.     

Effect of dietary lipid source on conjugated linoleic acid concentrations in milk fat

Conjugated linoleic acids (CLA) found in ruminant milk fat are a byproduct of incomplete biohydrogenation of lipids by ruminal bacteria. We examined the effect of different dietary fat supplements and processing methods on CLA. In trial 1, dietary supplements of Ca salts of fatty acids from canola oil, soybean oil, and linseed oil increased CLA content of milk fat by three- to fivefold over the control diet. Trials 2 and 3 examined the effect of processing methods for heat treatment of full fat soybeans. In trial 2, extrusion, micronizing, and roasting resulted in two- to threefold greater concentrations of CLA in milk fat than the control diet (raw ground soybeans). In trial 3, different temperatures of extrusion (120, 130, and 140 degrees C) increased the CLA content of milk fat to a similar extent; CLA averaged 19.9 mg/g of fatty acids for the extrusion treatments compared with 4.2 mg/g of fatty acids for the control diet (raw ground soybeans). Fish oil (200 and 400 ml/d) was examined in trial 4 and both levels resulted in CLA concentrations in milk fat that were about threefold greater than the control diet. In trial 5, grain and silage from a high oil corn hybrid increased the CLA content of milk fat; however, responses were modest with the CLA concentration (mg/g of fatty acids) averaging 4.6 and 2.8 for diets with high oil hybrid and normal hybrid, respectively. Similarly, dietary supplements of animal fat byproducts (tallow plus yellow grease; trial 6) resulted in modest increases in the CLA content of milk fat. Overall, several dietary manipulations involving lipid sources and processing methods were identified that allow for a marked increase in the conjugated linoleic acid content of milk fat.     

Influence of a dry fractionation of butterfat on the content of fatty acids including conjugated linoleic acids

There is a growing demand among consumers for food products with natural nutritional–physiological advantages over comparable conventional products. As part of an EU project, a process using dry fractionation is evaluated that enables the targeted low-input enrichment of conjugated linoleic acids (CLA) in milk fat. Furthermore, the distribution of CLA isomers in the fat fractions was analysed. In the olein fraction for highland butter a CLA enrichment of 15.3% was obtained. The yield of the CLA rich olein fraction was 44.5% of the total amount of olein and stearin. There were significant increases during the first fractionation step of highland butter for the concentration of the CLA isomer cis-9, trans-11 (P ≤ 0.05) and during the second fractionation step for the concentration of CLA isomers cis-9, trans-11; trans-11, cis-13 (P ≤ 0.05) and trans-7, cis-9 (P ≤ 0.01). Experiments carried out demonstrate that the selected physical separation process enables CLA enrichment but the increase is too minor to achieve any decisive positive impact on human health and therefore too costly as an industrial CLA enrichment process.     

Seasonal variation in cis-9, trans-11 conjugated linoleic acid content in milk fat from Nordic countries

We investigated the content of cis-9, trans-11 isomer of conjugated linoleic acid (CLA) and its seasonal variation in bovine milk fat from Denmark, Finland, Iceland, Norway, and Sweden. Milk samples were collected during winter and summer and analyzed using gas chromatography. The CLA content in milk samples from the Nordic countries ranged from 0.41 to 1.02 g/100 g total fatty acids. The CLA content was higher in Iceland (0.64 +/- 0.02) than in the other countries together (0.57 +/- 0.02), and the concentration in Icelandic and Danish milk (0.63 +/- 0.03) was higher than in Finnish milk (0.48 +/- 0.02) in a comparison of single countries. The CLA concentration during summer was on average 41.6% (11.9) higher than during winter (0.48 g/100 g (0.03) vs. 0.068 g/100 g (0.07)). Season exerted similar changes in all 5 countries. The concentration of CLA in milk fat from the Nordic countries seems lower than in milk from European countries reported previously in the literature, which may be due to shorter summers and longer winters in the Nordic countries. Health implications of varying concentrations of CLA need to be studied.     

Effect of tomato by-products in the diet of Comisana sheep on composition and conjugated linoleic acid content of milk fat

To evaluate the effect of supplementing the diet of Comisana sheep with by-products from industrial tomato manufacture on the fat composition and conjugated linoleic acid (CLA) content of milk fat, two groups of 50 ewes each were fed either total mixed ration standard (TMRS) or total mixed ration with added tomato by-products (TMRA). Milk fat composition was determined by high-resolution gas chromatography (HRGC). The milk fat content for the animals fed the TMRA diet increased by 6.41% (P < 0.01) after six weeks, compared with the animals fed the TMRS diet. The CLA content in the milk fat for the group of animals fed the TMRA diet was 19.8% (P < 0.05) higher than for those fed the TMRS diet, and reached 1.33 g 100 g^?1 fat, while the polyunsaturated fatty acid (PUFA) content increased by a 6.43% (P < 0.05) and reached 7.12 g 100 g^?1 fat. The fatty acid composition showed an increase in the amount of polyunsaturated fatty acids. The n ? 3:n ? 6 ratio increased by 13% in the milk from sheep fed with the TMRA diet. These observations were confirmed by triglyceride analysis, which showed a decrease in the amount of short-chain (C₂₈–C₃₂) and medium-chain (C₃₄–C₄₂) triglycerides after six weeks, while the opposite was observed for the long-chain triglycerides (C₄₄–C₅₄).     

酶法拆分共轭亚油酸异构体的响应面优化

利用响应面法优化了酶法酯化拆分共轭亚油酸异构体的工艺条件,最佳条件为：乙醇添加量0．16g/g（以CLA为基准）,pH6．5,温度26℃。在此条件下,反应12h后,酯化率可以达到45．8％,其中乙酯中c9,t11-CLA含量达到56．22％,t10,c12-CLA的含量达到21．63％。     

Conjugated linoleic acid and other anticarcinogenic agents of bovine milk fat.

Prevention is an important strategy for conquering cancer. Milk fat contains a number of components, such as conjugated linoleic acid, sphingomyelin, butyric acid, ether lipids, beta-carotene, and vitamins A and D that have anticancer potential. Conjugated linoleic acid inhibits the growth of a number of human cancer cell lines and suppresses chemically-induced tumor development at a number of sites in animal models. As little as 0.1% of dietary conjugated linoleic acid inhibits the development of rat mammary tumors, independent of the amount and type of fat in the diet. Sphingomyelin, through its metabolites ceramide and sphingosine, participates in multiple antiproliferative pathways associated with suppression of carcinogenesis. Dietary sphingomyelin inhibits murine colon tumor development. Butyric acid, uniquely present in ruminant milk, is a potent antineoplastic agent and may ameliorate its potency through synergy with other milk fat components. Dietary butyric acid inhibits mammary carcinoma development in rats. In humans, ether lipids, beta-carotene, and vitamins A and D are associated with anticancer effects. Cows have the ability to extract anticarcinogenic components from pasture and feed and transfer them to milk. Use of genetic engineering and other techniques to increase the range and level of anticarcinogens in pasture and supplements may increase the anticancer potential of milk.     

牛奶中共轭亚油酸含量的紫外分光光度测定方法

研究了牛乳中共轭亚油酸含量的紫外分光光度测定方法。利用紫外分光光度计,先建立标准曲线与回归公式,再将牛奶样品提取、甲酯化后,进行紫外检测。结果表明,共轭亚油酸甲酯的最大吸收波长是234nm;共轭亚油酸浓度的有效测定范围是0.00856-0.0428mg/mL;吸光度与共轭亚油酸浓度间的回归公式为Y=52.602X 0.0917(R2=0.9862);得出共轭亚油酸浓度与吸光度之间的经验公式为:共轭亚油酸浓度C(mg/mL)=0.019×吸光度(ABS);并且推出了利用紫外分光光度法测定牛奶中共轭亚油酸含量的计算公式。同时,检验了几种市售牛奶中共轭亚油酸,其平均含量为1.64mg/g。     

瘤胃微生物转化的富含共轭亚油酸乳对小白鼠脂肪沉积的影响

试验在奶牛日粮中添加葵花油,通过饲养试验获得富含共轭亚油酸乳,并以此乳饲喂4周龄的雄性昆明种小白鼠,研究瘤胃微生物转化的CLA功能乳对小白鼠脂肪沉积的影响.结果表明,在奶牛日粮中添加5%的葵花油,可使牛奶乳脂中共轭亚油酸质量分数增加到21.36 mg/g.通过生物转化生产的CLA功能乳能显著降低小白鼠增体质量、腹脂质量、体脂质量、甘油三酯、总胆固醇、低密度脂蛋白胆固醇质量分数与动脉硬化指数,增加高密度脂蛋白胆固醇与脂肪酶质量分数,对脂蛋白脂酶的影响不显著.     

Conjugated linoleic acid in ewe milk fat

Ewe milk fat from five different herds was studied to determine the content of conjugated linoleic acid (CLA) isomers. Research was carried out by combining gas chromatography-mass spectrometry (GC-MS) of fatty acid methyl esters (FAME) and 4,4-dimethyloxazolyne derivatives (DMOX) with silver ion-high performance liquid chromatography (Ag+-HPLC). Reconstructed mass spectral profiles of CLA characteristic ions from DMOX were used to identify positional isomers and Ag+-HPLC to quantify them. Total CLA content varied from 0.57 to 0.97 g/100 g of total fatty acids. FAME and DMOX were separated into a complex mixture of minor isomers and major rumenic acid (9-cis 11-trans C18:2) by GC-MS using a 100-m polar capillary column. Rumenic acid would represent more than 75% of total CLA. 11-trans 13-trans, 11-13 cis/trans plus trans/cis and 7-9 cis/trans plus trans/cis were the main CLA isomers after rumenic acid. Minor amounts of 8-10 and 10-12 C18:2 isomers were also found. Although most of the isomers were present in each herd's milk, differences in content were observed for some CLA species.     

Distribution and fatty acid content of phospholipids from bovine milk and bovine milk fat globule membranes

The phospholipid (PL) content was determined comparatively in the milk fat globule membrane (MFGM) and whole milk including their fatty acid profiles. The possible role of milk PLs in defence against pathogens was also addressed. The MFGM and whole milk showed a similar distribution of PL species; however, the fatty acid contents of the PL species were different. Total PL from MFGM showed a decrease in C18:0 content in parallel with an increase in C18:1 and C18:2 and very long-chain fatty acid (more than C20) content. No significant differences in the fatty acid content of phosphatidylcholine and sphingomyelin from either source were found. However, the phosphatidylethanolamine from MFGM had more C18:1 and C18:2 and less C14:0 and C16:0 than that from whole milk. A similar but less pronounced result was found for phosphatidylserine/phosphatidylinositol. Enterotoxigenic Escherichia coli strains failed to bind to PL, which had been previously separated by high-performance thin-layer chromatography.     

热处理对乳中CLA含量的影响

目的:研究了不同热处理对乳中CLA含量的影响,同时探讨了UHT奶贮存过程中CLA含量的变化.方法:选用原料奶进行常规巴氏杀菌、煮沸和UHT热处理,分析样品的CLA含量,同时测定UHT奶贮存1、7、14、28d后CLA含量的变化.结果:原料奶中CLA含量最高,为5.306±0.097me/g脂肪酸,UHT奶中CLA含量最低,为4.772±0·180mg/g脂肪酸.下降10.06%.煮沸奶和UHT奶中CLA含量显著低于原料奶(P＜0.05),而常规杀菌奶与原料奶无显著差异(P＞0.05).在保质期内,UHT奶的CLA含量变化差异不显著(P＞0.05).结论:煮沸和UHT热处理会影响奶中CLA含量,UHT奶贮存过程中对CLA含量无显著影响.     

Mechanisms of body fat modulation by conjugated linoleic acid (CLA)

Since its discovery as an anticancer principal from ground beef extract in the 1980s, conjugated linoleic acid (CLA) has drawn much attention due to its variety of biological activities. One of the most interesting aspects of CLA is its ability to reduce body fat while enhancing lean body mass. One explanation for the variety of biological activities of CLA is that CLA is a mixture of geometric and positional isomers, although the primary research focus is on the two main isomers, cis-9,trans-11 and trans-10,cis-12. The involvement of eicosanoid metabolism has been suggested as one mechanism for CLAs wide range of biological activities. Incorporation of CLA in the sn-2 position of phospholipid fractions, and the negative correlation between tissue levels of CLA and arachidonic acid support this. Other possible mechanisms of CLA with regard to body fat reduction will be discussed, as well as differences between human and animal studies. Safety concerns regarding the use of CLA in humans are not conclusive and need further investigation.     

酶法拆分制备共轭亚油酸功能单体

研究利用Lipase AYS催化甲醇和共轭亚油酸(CLA)进行酯化反应,以期对共轭亚油酸异构体进行拆分制备共轭亚油酸功能单体。通过考察酯化反应的影响因素,确定了最优反应条件为:Lipase AYS加酶量180 U/g,反应温度40℃,CLA与甲醇摩尔比1∶1,缓冲液p H 6.5。在最优条件下反应8 h,总酯化率为49.5%,分离产物可以得到甲酯相与脂肪酸相,甲酯相中c9,t11-CLA甲酯的拆分效率达到86.2%,脂肪酸相中t10,c12-CLA的拆分效率达到80.0%,两者回收率分别为72.4%和54.2%。     

Trans-9, cis-11 conjugated linoleic acid reduces milk fat synthesis in lactating dairy cows

Under certain dietary situations, rumen biohydrogenation results in the production of unique fatty acids that inhibit milk fat synthesis. The first of these to be identified was trans-10, cis-12 conjugated linoleic acid (CLA), but others are postulated to contribute to diet-induced milk fat depression (MFD). Our objective was to examine the potential role of trans-9, cis-11 CLA in the regulation of milk fat. In a preliminary study, we used gas-liquid and high-performance liquid chromatography techniques to examine milk fat samples from a diet-induced MFD study and found that an increase in trans-9, cis-11 CLA corresponded to the decrease in milk fat yield. We investigated this further using a CLA enrichment of 9, 11 isomers to examine the biological effect of trans-9, cis-11 CLA on milk fat synthesis. Four rumen-fistulated Holstein cows were randomly assigned in a 4 × 4 Latin square experiment involving 5-d treatment periods and abomasal infusion of 1) ethanol (control), 2) a 9, 11 CLA mix (containing 32% trans-9, cis-11, 29% cis-9, trans-11, and 17% trans-9, trans-11), 3) a trans-9, trans-11 CLA supplement, and 4) a trans-10, cis-12 CLA supplement (positive control). The trans-9, trans-11 CLA and trans-10, cis-12 CLA supplements were of high purity (>90%), and all supplements were infused at a rate to provide 5 g/d of the CLA isomer of interest. Milk yield and dry matter intake did not differ among treatments. Compared with the control treatment, milk fat yield was reduced by 15% for the 9, 11 CLA mixture and by 27% for the trans-10, cis-12 CLA treatment. We also found that trans-9, trans-11 CLA had no effect on milk fat yield, and previous research has shown that milk fat yield is unaltered when cows are infused with cis-9, trans-11 CLA. When all treatments were considered, results suggested that trans-9, cis-11 was the CLA isomer in the 9, 11 CLA mix responsible for the reduction in milk fat synthesis, although the magnitude was less than that observed for trans-10, cis-12 CLA. Interestingly, trans-9, trans-11 CLA altered the milk fat desaturase index, further demonstrating that alterations in desaturase can occur independently of effects on milk fat synthesis. Overall, our investigations identified that an increase in milk fat content of trans-9, cis-11 CLA was associated with diet-induced MFD and provided evidence of a role for this isomer in MFD based on the 15% reduction in milk fat yield with abomasal infusion of a CLA enrichment that supplied 5 g/d of trans-9, cis-11 CLA.     

Effect of safflower oil, flaxseed oil, monensin, and vitamin E on concentration of conjugated linoleic acid in bovine milk fat

Conjugated linoleic acid (CLA) refers to a mixture of conjugated octadecadienoic acids of predominantly ruminant origin. The main isomer in bovine milk fat is the cis-9, trans-11 CLA. Interest in CLA increased after the discovery of its health-promoting properties, including potent anticarcinogenic activity. Two experiments were conducted to evaluate dietary strategies aimed at increasing the concentration of CLA in bovine milk fat. Both experiments were organized as a randomized complete block design with a repeated measures treatment structure. In Experiment 1, 28 Holstein cows received either a control diet or one of 3 treatments for a period of 2 wk. The control diet consisted of 60% forage (barley silage, alfalfa silage, and alfalfa hay) and 40% concentrate on a dry matter (DM) basis, fed as a total mixed ration (TMR). The concentrate was partially replaced in the treatment groups with 24 ppm of monensin (MON), 6% of DM safflower oil (SAFF), or 6% of DM safflower oil plus 24 ppm of monensin (SAFF/M). Average cis-9, trans-11 CLA levels in milk fat after 2 wk of feeding were 0.45, 0.52, 3.36, and 5.15% of total fatty acids for control, MON, SAFF, and SAFF/M, respectively. In Experiment 2, 62 Holstein cows received either a control diet or one of 5 treatment diets for a period of 9 wk. The control diet consisted of 60% forage (barley silage, alfalfa silage, and alfalfa hay) and 40% concentrate on a DM basis, fed as a TMR. The concentrate was partially replaced in the treatment groups with 6% of DM safflower oil (SAFF), 6% of DM safflower oil plus 150 IU of vitamin E/kg of DM (SAFF/E), 6% of DM safflower oil plus 24 ppm of monensin (SAFF/M), 6% of DM safflower oil plus 24 ppm of monensin plus 150 IU of vitamin E/kg of DM (SAFF/ME), or 6% of DM flaxseed oil plus 150 IU of vitamin E/kg of DM (FLAX/E). Average cis-9, trans-11 CLA levels during the treatment period were 0.68, 4.12, 3.48, 4.55, 4.75, and 2.80% of total fatty acids for control, SAFF, SAFF/E, SAFF/M, SAFF/ME, and FLAX/E, respectively. The combination of safflower oil with monensin was particularly effective at increasing milk fat CLA. The addition of vitamin E to the diet partially prevented the depression in milk fat associated with oilseed feeding, but had no significant effect on the concentration of CLA in milk.